What's new in contemporary ophthalmic drug delivery systems: Understanding the latest innovative technologies.

This article discusses the latest innovative technologies in ophthalmic drug delivery systems. It highlights the challenges faced in the administration of ophthalmic drugs, such as frequency of administration, adherence, duration, and ineffective bioavailability. The article focuses on topical ophthalmic drug delivery systems, including recent FDA-approved drugs for the treatment of dry eye disease, presbyopia, and retinal conditions. It emphasizes the importance of understanding these advancements for better patient care and mentions the potential improvements in in-office dilation. However, it notes that the article is not a comprehensive list of approved options and encourages readers to stay updated on new drug delivery systems. [Extracted from the article]